North America Tissue Engineered – Skin Substitutes Market Outlook to 2025

“What is covered in the report about the “North America Tissue Engineered – Skin Substitutes Market”?

GlobalData’s “North America Tissue Engineered – Skin Substitutes Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the North America Tissue Engineered – Skin Substitutes market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Acellular Skin Substitutes and Cellular Skin Substitutes.

The North America Tissue Engineered – Skin Substitutes Market report provides key information and data on

• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.

• 2018 company share and distribution share data for Tissue Engineered – Skin Substitutes market.

• Global corporate-level profiles of key companies operating within the North America Tissue Engineered – Skin Substitutes Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

North America Tissue Engineered – Skin Substitutes is segmented as follows:

• Acellular Skin Substitutes

• Cellular Skin Substitutes

Key Reasons to Purchase

The North America Tissue Engineered – Skin Substitutes Market report helps you to develop

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “North America Tissue Engineered – Skin Substitutes Market Outlook to 2025” report

• Allergan Plc

• MiMedx Group Inc

• Organogenesis Inc

The GlobalData Differentiation

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 15,000+ primary interviews, conducted annually to ensure data and report quality

• 3,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape

• 66.956+ medical equipment company profiles

• 4,300+ company profiles of medical equipment manufacturers in China and India

• 825+ companies’ revenue splits and market shares

• 2,000+ quarterly and annual medical equipment company financials

• 1,100+ medical equipment company SWOTs

• 26,400+ pipeline product profiles

• 52,400+ marketed product profiles

• 44,600+ clinical trials

• 52,400+ trial investigators

• 7,900+ reports on companies with products in development

• 42,000+ deals in the medical equipment industry

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Tissue Engineered – Skin Substitutes Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Tissue Engineered – Skin Substitutes Market, North America 9

3.1 Tissue Engineered – Skin Substitutes Market, North America, Revenue ($m), 2015-2025 9

3.2 Tissue Engineered – Skin Substitutes Market, North America, Revenue ($m), 2015-2025 11

3.3 Tissue Engineered – Skin Substitutes Market, North America, Volume (Units), 2015-2025 13

3.4 Tissue Engineered – Skin Substitutes Market, North America, Volume (Units), 2015-2025 15

3.5 Tissue Engineered – Skin Substitutes Market, North America, Company Share by Revenue ($m), 2018 17

4 Tissue Engineered – Skin Substitutes Market, Canada 19

4.1 Tissue Engineered – Skin Substitutes Market, Canada, Revenue ($m), 2015-2025 19

4.1.1 Acellular Skin Substitutes Market, Canada, Revenue ($m), by Segment, 2015-2025 21

4.1.2 Cellular Skin Substitutes Market, Canada, Revenue ($m), by Segment, 2015-2025 23

4.2 Tissue Engineered – Skin Substitutes Market, Canada, Volume (Units), 2015-2025 25

4.2.1 Acellular Skin Substitutes Market, Canada, Volume (Units), by Segment, 2015-2025 27

4.2.2 Cellular Skin Substitutes Market, Canada, Volume (Units), by Segment, 2015-2025 29

4.3 Tissue Engineered – Skin Substitutes Market, Canada, Average Price ($), 2015-2025 31

4.4 Tissue Engineered – Skin Substitutes Market, Canada, Distribution Share by Revenue ($m), 2018 32

4.5 Tissue Engineered – Skin Substitutes Market, Canada, Company Share by Revenue ($m), 2018 33

5 Tissue Engineered – Skin Substitutes Market, Mexico 35

5.1 Tissue Engineered – Skin Substitutes Market, Mexico, Revenue ($m), 2015-2025 35

5.1.1 Acellular Skin Substitutes Market, Mexico, Revenue ($m), by Segment, 2015-2025 37

5.1.2 Cellular Skin Substitutes Market, Mexico, Revenue ($m), by Segment, 2015-2025 39

5.2 Tissue Engineered – Skin Substitutes Market, Mexico, Volume (Units), 2015-2025 41

5.2.1 Acellular Skin Substitutes Market, Mexico, Volume (Units), by Segment, 2015-2025 43

5.2.2 Cellular Skin Substitutes Market, Mexico, Volume (Units), by Segment, 2015-2025 45

5.3 Tissue Engineered – Skin Substitutes Market, Mexico, Average Price ($), 2015-2025 47

5.4 Tissue Engineered – Skin Substitutes Market, Mexico, Distribution Share by Revenue ($m), 2018 48

5.5 Tissue Engineered – Skin Substitutes Market, Mexico, Company Share by Revenue ($m), 2018 49

6 Tissue Engineered – Skin Substitutes Market, United States 51

6.1 Tissue Engineered – Skin Substitutes Market, United States, Revenue ($m), 2015-2025 51

6.1.1 Acellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025 53

6.1.2 Cellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025 55

6.2 Tissue Engineered – Skin Substitutes Market, United States, Volume (Units), 2015-2025 57

6.2.1 Acellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2015-2025 59

6.2.2 Cellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2015-2025 61

6.3 Tissue Engineered – Skin Substitutes Market, United States, Average Price ($), 2015-2025 63

6.4 Tissue Engineered – Skin Substitutes Market, United States, Distribution Share by Revenue ($m), 2018 64

6.5 Tissue Engineered – Skin Substitutes Market, United States, Company Share by Revenue ($m), 2018 65

7 Overview of Key Companies in North America Tissue Engineered – Skin Substitutes Market 67

7.1 Allergan Plc 67

7.1.1 Company Overview 67

7.2 LifeNet Health Inc 67

7.2.1 Company Overview 67

7.3 Derma Sciences Inc 67

7.3.1 Company Overview 67

7.4 Smith & Nephew Plc 68

7.4.1 Company Overview 68

7.5 Acelity Holdings, Inc. 68

7.5.1 Company Overview 68

7.6 MiMedx Group Inc 68

7.6.1 Company Overview 68

7.7 Organogenesis Inc 68

7.7.1 Company Overview 68

8 Tissue Engineered – Skin Substitutes Market Pipeline Products 69

9 Recent Developments 70

9.1 Corporate Communications 70

9.1.1 May 30, 2019: MiMedx announces comprehensive board refreshment plan in cooperation with prescience point 70

9.1.2 May 09, 2019: MiMedx appoints Timothy R. Wright as Chief Executive Officer 72

9.1.3 Apr 30, 2019: Anika Therapeutics names Stephen Goldy as vice president of U.S. Sales 72

9.1.4 Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer 73

9.1.5 Mar 18, 2019: Anika Therapeutics names Robert Richard as Vice President of research and development 73

9.1.6 Jan 28, 2019: BIOLIFE4D names Management Advisory Board 74

9.1.7 Dec 05, 2018: MiMedx Announces Leadership Changes And Promotions 75

9.1.8 Nov 08, 2018: Mr. Matthew Dallas and Mr. Jeffrey Young appointed to Biostage Board of Directors 75

9.1.9 Nov 07, 2018: Biostage names Ms. Ting Li as board director 76

9.1.10 Oct 24, 2018: Anika Therapeutics names Susan Vogt as Board Director 76

9.1.11 Sep 05, 2018: Anika appoints Dr. Cheryl Blanchard to its Board of Directors 77

9.1.12 Jul 02, 2018: MiMedx Announces Leadership Changes And Corporate Actions 78

9.2 Financial Announcements 79

9.2.1 May 14, 2019: Biostage announces first quarter 2019 financial results 79

9.2.2 May 02, 2019: Smith & Nephew first quarter 2019 trading report 80

9.2.3 May 02, 2019: Anika reports first quarter 2019 financial results 82

9.2.4 Apr 12, 2019: Kuros Biosciences reports results for the full year 2018 82

9.2.5 Feb 21, 2019: Anika reports fourth quarter and full year 2018 financial results 84

9.2.6 Nov 08, 2018: Biostage reports 2018 third quarter financial results 85

9.2.7 Oct 24, 2018: Anika Therapeutics announces Third Quarter 2018 Financial Results 86

9.2.8 Aug 22, 2018: Novoheart Holdings announces fourth quarter and fiscal 2018 financial results 87

9.2.9 Jul 25, 2018: Anika reports second quarter 2018 financial results 88

9.3 Government and Public Interest 89

9.3.1 Dec 12, 2018: Growing skin in the lab for the treatment of advanced wounds 89

9.4 Legal And Regulatory 90

9.4.1 Aug 20, 2018: MiMedx announces Nasdaq listing extension 90

9.5 Other Significant Developments 90

9.5.1 Jun 05, 2019: MiMedx issues new presentation for investors in advance Of 2018 Annual Meeting 90

9.5.2 May 20, 2019: Scientists use molecular tethers and chemical ‘light sabers’ to construct platforms for tissue engineering 91

9.5.3 Nov 01, 2018: Smith & Nephew third quarter 2018 trading report 92

9.5.4 Sep 06, 2018: Hesperos Human-on-a-Chip technology awarded $4 million phase IIb SBIR grant 94

9.5.5 Aug 01, 2018: Lions Eye Institute and RTI Donor Services expand strategic relationship to maximize the gift of tissue donation 95

9.5.6 Aug 01, 2018: BloodCenter of Wisconsin and RTI Donor Services Expand Strategic Relationship to Maximize the Gift of Tissue Donation 95

9.5.7 Jul 26, 2018: Ren breathes life into damaged lungs 96

9.5.8 Jun 25, 2018: BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue 97

9.6 Product News 98

9.6.1 Jan 07, 2019: 3Scan hosts San Francisco Biotech Showcase with Prellis Biologics and announces real human tissue structures for R&D bioprinting with the Holograph-X 98

9.6.2 Jun 20, 2018: Collaboration With Frampton Lab To 3D Print Skin Tissue 98

9.7 Strategy And Business Planning 99

9.7.1 Dec 05, 2018: MiMedx Announces Organizational Realignment Program 99

10 Appendix 101

10.1 Research Methodology 102

10.1.1 Coverage 102

10.1.2 Secondary Research 102

10.1.3 Primary Research 103

10.1.4 Market Modeling and Forecasting 104

10.1.5 Company Share Analysis 105

10.1.6 Distribution Share Analysis 106

10.1.7 Benchmarking 106

10.2 GlobalData Consulting 106

10.3 Contact Us 107

10.4 Disclaimer 10

List of Tables

1.1 List of Tables

Table 1: Tissue Engineered – Skin Substitutes Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 10

Table 2: Tissue Engineered – Skin Substitutes Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020 12

Table 3: Tissue Engineered – Skin Substitutes Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025 12

Table 4: Tissue Engineered – Skin Substitutes Market, North America, Volume (Units), 2015-2025 14

Table 5: Tissue Engineered – Skin Substitutes Market, North America, Volume (Units), 2015-2020 16

Table 6: Tissue Engineered – Skin Substitutes Market, North America, Volume (Units), 2021-2025 16

Table 7: Tissue Engineered – Skin Substitutes Market, North America, Company Share by Revenue ($m), USD Constant, 2018 18

Table 8: Tissue Engineered – Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2020 20

Table 9: Tissue Engineered – Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2021-2025 20

Table 10: Acellular Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2020 22

Table 11: Acellular Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2021-2025 22

Table 12: Cellular Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2020 24

Table 13: Cellular Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2021-2025 24

Table 14: Tissue Engineered – Skin Substitutes Market, Canada, Volume (Units), 2015-2020 26

Table 15: Tissue Engineered – Skin Substitutes Market, Canada, Volume (Units), 2021-2025 26

Table 16: Acellular Skin Substitutes Market, Canada, Volume (Units), 2015-2020 28

Table 17: Acellular Skin Substitutes Market, Canada, Volume (Units), 2021-2025 28

Table 18: Cellular Skin Substitutes Market, Canada, Volume (Units), 2015-2020 30

Table 19: Cellular Skin Substitutes Market, Canada, Volume (Units), 2021-2025 30

Table 20: Tissue Engineered – Skin Substitutes Market, Canada, Average Price ($), 2015-2020 31

Table 21: Tissue Engineered – Skin Substitutes Market, Canada, Average Price ($), 2021-2025 31

Table 22: Tissue Engineered – Skin Substitutes Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2018 32

Table 23: Tissue Engineered – Skin Substitutes Market, Canada, Company Share by Revenue ($m), USD Constant, 2018 34

Table 24: Tissue Engineered – Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2015-2020 36

Table 25: Tissue Engineered – Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2021-2025 36

Table 26: Acellular Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2015-2020 38

Table 27: Acellular Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2021-2025 38

Table 28: Cellular Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2015-2020 40

Table 29: Cellular Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2021-2025 40

Table 30: Tissue Engineered – Skin Substitutes Market, Mexico, Volume (Units), 2015-2020 42

Table 31: Tissue Engineered – Skin Substitutes Market, Mexico, Volume (Units), 2021-2025 42

Table 32: Acellular Skin Substitutes Market, Mexico, Volume (Units), 2015-2020 44

Table 33: Acellular Skin Substitutes Market, Mexico, Volume (Units), 2021-2025 44

Table 34: Cellular Skin Substitutes Market, Mexico, Volume (Units), 2015-2020 46

Table 35: Cellular Skin Substitutes Market, Mexico, Volume (Units), 2021-2025 46

Table 36: Tissue Engineered – Skin Substitutes Market, Mexico, Average Price ($), 2015-2020 47

Table 37: Tissue Engineered – Skin Substitutes Market, Mexico, Average Price ($), 2021-2025 47

Table 38: Tissue Engineered – Skin Substitutes Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2018 48

Table 39: Tissue Engineered – Skin Substitutes Market, Mexico, Company Share by Revenue ($m), USD Constant, 2018 50

Table 40: Tissue Engineered – Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2020 52

Table 41: Tissue Engineered – Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2021-2025 52

Table 42: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2020 54

Table 43: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2021-2025 54

Table 44: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2020 56

Table 45: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2021-2025 56

Table 46: Tissue Engineered – Skin Substitutes Market, United States, Volume (Units), 2015-2020 58

Table 47: Tissue Engineered – Skin Substitutes Market, United States, Volume (Units), 2021-2025 58

Table 48: Acellular Skin Substitutes Market, United States, Volume (Units), 2015-2020 60

Table 49: Acellular Skin Substitutes Market, United States, Volume (Units), 2021-2025 60

Table 50: Cellular Skin Substitutes Market, United States, Volume (Units), 2015-2020 62

Table 51: Cellular Skin Substitutes Market, United States, Volume (Units), 2021-2025 62

Table 52: Tissue Engineered – Skin Substitutes Market, United States, Average Price ($), 2015-2020 63

Table 53: Tissue Engineered – Skin Substitutes Market, United States, Average Price ($), 2021-2025 63

Table 54: Tissue Engineered – Skin Substitutes Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 64

Table 55: Tissue Engineered – Skin Substitutes Market, United States, Company Share by Revenue ($m), USD Constant, 2018 66

Table 56: Tissue Engineered – Skin Substitutes Market Pipeline Products 69

Table 57: Total Number of Primary Research Participants, Wound Care Management Market, by Country 104

List of Figures

1.2 List of Figures

Figure 1: Tissue Engineered – Skin Substitutes Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 9

Figure 2: Tissue Engineered – Skin Substitutes Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025 11

Figure 3: Tissue Engineered – Skin Substitutes Market, North America, Volume (Units), 2015-2025 13

Figure 4: Tissue Engineered – Skin Substitutes Market, North America, Volume (Units), 2015-2025 15

Figure 5: Tissue Engineered – Skin Substitutes Market, North America, Company Share (%) 2018 17

Figure 6: Tissue Engineered – Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2025 19

Figure 7: Acellular Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2025 21

Figure 8: Cellular Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2025 23

Figure 9: Tissue Engineered – Skin Substitutes Market, Canada, Volume (Units), 2015-2025 25

Figure 10: Acellular Skin Substitutes Market, Canada, Volume (Units), 2015-2025 27

Figure 11: Cellular Skin Substitutes Market, Canada, Volume (Units), 2015-2025 29

Figure 12: Tissue Engineered – Skin Substitutes Market, Canada, Company Share (%) 2018 33

Figure 13: Tissue Engineered – Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2015-2025 35

Figure 14: Acellular Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2015-2025 37

Figure 15: Cellular Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2015-2025 39

Figure 16: Tissue Engineered – Skin Substitutes Market, Mexico, Volume (Units), 2015-2025 41

Figure 17: Acellular Skin Substitutes Market, Mexico, Volume (Units), 2015-2025 43

Figure 18: Cellular Skin Substitutes Market, Mexico, Volume (Units), 2015-2025 45

Figure 19: Tissue Engineered – Skin Substitutes Market, Mexico, Company Share (%) 2018 49

Figure 20: Tissue Engineered – Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2025 51

Figure 21: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2025 53

Figure 22: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2025 55

Figure 23: Tissue Engineered – Skin Substitutes Market, United States, Volume (Units), 2015-2025 57

Figure 24: Acellular Skin Substitutes Market, United States, Volume (Units), 2015-2025 59

Figure 25: Cellular Skin Substitutes Market, United States, Volume (Units), 2015-2025 61

Figure 26: Tissue Engineered – Skin Substitutes Market, United States, Company Share (%) 2018 65

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports